Glentuss (Glendale Inc)


Welcome to the PulseAid listing for the Glentuss drug offered from Glendale Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Glendale Inc
NON-PROPRIETARY NAME: DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, and DOXYLAMINE SUCCINATE
SUBSTANCE NAME: DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SYRUP
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2015-12-05
END MARKETING DATE: 0000-00-00


Glentuss HUMAN OTC DRUG Details:

Item DescriptionGlentuss from Glendale Inc
LABELER NAME: Glendale Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 30; 6.25(mg/5mL; mg/5mL; mg/5mL)
START MARKETING DATE: 2015-12-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70147-233_f23182eb-a618-4556-a265-3de318cc7ae5
PRODUCT NDC: 70147-233
APPLICATION NUMBER: part341

Other DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Glendale IncGlentuss